作者: David E. Dawe , Jeffrey N. Greenspoon , Peter M. Ellis
DOI: 10.1016/J.CLLC.2014.04.008
关键词:
摘要: Up to 50% of patients with advanced non-small-cell lung cancer will develop brain metastases at some point during their illness. These cause a substantial burden in morbidity and mortality, which has motivated research technological innovation over the past 2 decades. Surgery, radiotherapy, systemic therapies have each played role management, greatest changes associated popularization stereotactic radiosurgery. In this review, evidence behind modality used management for is examined, recommendations regarding current standards care areas future focus are provided.